We are excited to announce OCCIDENT investing in Altavo and taking the lead in the oversubscribed €5 million Series A round. Altavo is a Dresden-based MedTech start-up with strong ties to the Technical University of Dresden.
Based on non-invasive radar sensing and innovative artificial intelligence algorithms, Altavo is developing an artificial voice with the vision of improving the rehabilitation and quality of life of aphonic and severely voice-impaired patients. The technology can be applied in various fields, such as for cancer patients who have lost their voice due to a laryngectomy or for patients during mechanical ventilation. In addition, Altavo’s technology opens up completely new opportunities in the field of silent communication and human-machine interfaces.
The funds will finance the product development, the pivotal clinical trial and the company’s growth.
More information in the press release under the following link
More about Altavo
